IL-17 inhibitors in PsO, PsA, ax-SpA; IL-12/23 inhibitors in PsO, PsA [133], CD, and SLE; IL-23 inhibitors in CD, UC, PsO, and PsA. Here, IL17A is linked to systemic lupus erythematosus.